Education
About Us
Working with TipRanks
Follow Us
Cannara Biotech (LOVFF)
OTHER OTC:LOVFF
LOVFF Stock Chart & Stats
$1.27
<$0.01(1.07%)
At close: 4:00 PM EST
$1.27
<$0.01(1.07%)
Day’s Range― - ―
52-Week Range$0.46 - $1.42
Previous CloseN/A
Volume3.00K
Average Volume (3M)2.46K
Market Cap
$121.05M
Enterprise Value$149.75M
Total Cash (Recent Filing)$14.36M
Total Debt (Recent Filing)$41.58M
Price to Earnings (P/E)12.4
Beta0.39
Next Earnings
Jan 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding94,895,900
10 Day Avg. Volume4,074
30 Day Avg. Volume2,464
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.24
Enterprise Value/Revenue1.39
Enterprise Value/Gross Profit3.15
Enterprise Value/Ebitda5.28
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Cannara Biotech News
LOVFF FAQ
What was Cannara Biotech’s price range in the past 12 months?
Cannara Biotech lowest stock price was $0.46 and its highest was $1.42 in the past 12 months.
What is Cannara Biotech’s market cap?
Cannara Biotech’s market cap is $121.05M.
When is Cannara Biotech’s upcoming earnings report date?
Cannara Biotech’s upcoming earnings report date is Jan 26, 2026 which is in 34 days.
How were Cannara Biotech’s earnings last quarter?
Cannara Biotech released its earnings results on Nov 24, 2025. The company reported $0.029 earnings per share for the quarter, beating the consensus estimate of N/A by $0.029.
Is Cannara Biotech overvalued?
According to Wall Street analysts Cannara Biotech’s price is currently Overvalued.
Does Cannara Biotech pay dividends?
Cannara Biotech does not currently pay dividends.
What is Cannara Biotech’s EPS estimate?
Cannara Biotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cannara Biotech have?
Cannara Biotech has 94,895,900 shares outstanding.
What happened to Cannara Biotech’s price movement after its last earnings report?
Cannara Biotech reported an EPS of $0.029 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 7.438%.
Which hedge fund is a major shareholder of Cannara Biotech?
Currently, no hedge funds are holding shares in LOVFF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cannara Biotech
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
LOVFF Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong financial performance with record-breaking metrics and significant market share growth in key regions and product categories. However, there are challenges in maintaining market share in certain regions and managing cash flow effectively.View all LOVFF earnings summariesTechnical Analysis
Jushi Holdings
―
OrganiGram Holdings
―
Auxly Cannabis Group
―
Planet 13 Holdings
―
Decibel Cannabis Company
―
Ownership Overview
Options Prices
Currently, No data available
---